CAMP4 Therapeutics Corpor...

NASDAQ: CAMP · Real-Time Price · USD
1.67
0.12 (7.74%)
At close: Aug 15, 2025, 3:59 PM
1.70
2.08%
After-hours: Aug 15, 2025, 07:52 PM EDT

CAMP4 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is March - February.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020 May 31, 2020
Net Income
-12.43M -13.28M -13.48M -12.58M -12.45M -12.99M -11.7M -4.03M -8.09M -4.73M -7.49M -12.17M -9.18M -10.54M -5.42M -6M 26.42M -23.68M -9.48M -14.42M
Depreciation & Amortization
421K 418K 418K 424K 436K 435K 430K 5.55M 5.66M 5.22M 5.39M 5.5M 5.72M 5.97M 5.64M 5.48M 1.4M 6.88M 6.92M 6.8M
Stock-Based Compensation
861K 797K 1.59M 786K 856K 636K 722K 2.18M 2.02M 2.03M 3.2M 2.96M 2.76M 3.15M 2.94M 2.47M 1.86M 3.03M 2.85M 3.62M
Other Working Capital
-3.9M 1.15M 229K -1.48M -1.4M -162K 3.13M -1.34M 972K 210K -431K -2.66M -3.68M -3.89M -3.84M -2.81M -3.88M 55K 2.12M -4.5M
Other Non-Cash Items
586K 479K 468K 412.5K 430K 448K 403K 709K 531K 688K 346K 413K 3.12M 2.55M 2.27M 2.21M -2.37M 2.43M 2.28M 2.48M
Deferred Income Tax
n/a -480K n/a n/a n/a n/a n/a -304K 544K 3K 20K 109K 76K 139K 87K 163K -373K 477K -254K 149K
Change in Working Capital
-3.72M 297K 1.31M -2.53M -413K -312K 3.59M -7.08M -1.76M 630K -11.58M -12.36M -10.02M -8.41M 4.87M -3.85M 3.24M 3.09M 5.59M 3.02M
Operating Cash Flow
-14.29M -15.27M -9.69M -13.44M -11.14M -11.78M -6.55M -2.98M -1.09M 3.83M -10.13M -15.55M -7.53M -7.14M 10.37M 78K 4.24M 10.22M 8.18M 5.94M
Capital Expenditures
-279K -263K n/a -163K -15K -243K -207K -1.96M -1.81M -4.4M -1.26M -3.63M -2.96M -3.77M -3.48M -3.09M -266K -3.53M -4.47M -3.09M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -6.26M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.26M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-279K -263K n/a -163K -15K -243K -207K -1.96M -1.81M -4.4M -1.26M -3.63M -2.96M -4.67M -3.48M 3.52M -2.6M -3.53M -4.47M -3.09M
Debt Repayment
-36K -96K -90K -89K -89K -121K -89K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-115K -3.16M -327K -723K -115K 58K -115K -257K -190K -107K -1.14M -425K -45K -111K -2.96M -1.06M -71K -16K -1.41M -136K
Financial Cash Flow
-151K 73.06M -386K -812K -202K -63K -203K -257K 264K -107K -641K -425K 585K -111K -2.3M -813K 987K -20.07M -519K -7.71M
Net Cash Flow
-14.72M 61.51M -10.08M -14.41M -11.36M -12.09M -6.96M -6.97M -2.98M -2.81M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow
-14.56M -11.55M -9.69M -13.6M -11.16M -12.03M -6.76M -4.94M -2.9M -569K -11.39M -19.18M -10.49M -10.91M 6.9M -3.02M 3.98M 6.7M 3.71M 2.85M